NCI   NIH
Mouse Models of Human Cancers Consortium
Search: 
Site Map
Gastrointestinal Cancer Models Site Navigation  
1.0 Human Colorectal Cancer
1.1 Development and Biology of the Gastrointestinal system
1.2 Tumor Classification and Staging
1.3 Molecular Alterations
1.4 Novel Therapeutics
2.0 Murine Intestinal Neoplasia
2.1 Murine Models of Colorectal Cancer
2.2 Classification of Murine Intestinal Tumors
Contributors
References
Resources  
1. Gastrointestinal Cancer Models Publications (PubMed)  Opens in New Window: 1. Gastrointestinal Cancer Models Publications (PubMed)
2. Gastrointestinal SPOREs  Opens in New Window: 2. Gastrointestinal SPOREs
3. Gastrointestinal Cancer Models (MMHCC)  Opens in New Window: 3. Gastrointestinal Cancer Models (MMHCC)
4. Gastrointestinal Cancer Models (MMHCC Repository)  Opens in New Window: 4. Gastrointestinal Cancer Models (MMHCC Repository)
5. Intestine Cancer Models (MTB)  Opens in New Window: 5. Intestine Cancer Models (MTB)
6. Intestine Cancer Metastases Models (MTB)  Opens in New Window: 6. Intestine Cancer Metastases Models (MTB)
7. Digestive System Cancer Models (MTB)  Opens in New Window: 7. Digestive System Cancer Models (MTB)
8. Digestive System Cancer Metastases Models (MTB)  Opens in New Window: 8. Digestive System Cancer Metastases Models (MTB)
9. Colon Cancer Chemoprevention Potency Database  Opens in New Window: 9. Colon Cancer Chemoprevention Potency Database

skip top level navigationHome Mouse Models Experimental Therapeutics Resources MMHCC Communication Bioinformatics Learning Tools  

  Emice  >  Mouse Models  >  Organ Site Models  >  Gastrointestinal Cancer Models  >  Murine Intestinal Neoplasia  >  Murine Models of Colorectal Cancer  >  Mouse Models of Intestinal Cancer :

Mouse Models of Intestinal Cancer

Mouse Models of Intestinal Cancer

(Reprinted with permission from Boivin et al., 2003)

 

 

Name of Model

Background Strain

Predominant Location

Predominant Neoplasm

Average Number of Tumors/ Mouse

Age when

Analyzed

Other lesions

Metastasis

Reference

WNT Pathway

 

 

 

 

 

 

 

 

ApcMin/+

C57BL/6

Small Intestine

Adenoma

30

4 months

carcinoma

no

61

Apc1638N/+

C57BL/6

Small Intestine

Adenoma/Carcinoma

4

12 months

desmoid tumors

Yes (1 reported)

78, 64

ApcD716/+

C57BL/6

Small Intestine

Adenoma

300

4 months

 

no

63

Apc1309/+

NR

Small Intestine

Adenoma

34

3 months

 

no

98

DN131 b-catenin

C57BL/6 x DBA

Small Intestine

Adenoma

1

1 month

polycystic renal disease

no

66

Activated b-catenin

C57BL/6 x NR

Small Intestine

Adenoma

3000

1 month

 

no

68

Mismatch repair genes

 

 

 

 

 

 

 

 

Msh3-/-

C57BL/6 x 129/Sv x SJL/J

Small Intestine

Adenoma/Carcinoma

<1

24 months

lymphomas, skin tumors

no

72

Msh3-/- Apc1638/+

C57Bl/6

Small/large intestine

Adenoma/Carcinoma

5

9 months

skin tumor

no

80

Msh6-/-

C57BL/6 x 129/SvJ x SJL/J

Small Intestine

Adenoma/Carcinoma

<1

11 months

lymphomas, skin tumors

no

73

Msh6-/- Apc1638/+

C57Bl/6

Small/Large Intestine

Adenoma/Carcinoma

26

5 months

skin tumor

no

80

Msh3-/- Msh6-/-

129/Ola x FVB/N

Small Intestine

Adenoma/Carcinoma

1

6 months

skin tumor

no

72

Msh3-/-Msh6-/-Apc1638/+

C57Bl/6

Small/Large Intestine

Adenoma/Carcinoma

40

<3 months

 

no

80

Mlh1-/-

C57BL/6 x 129/Ola

Small Intestine

Adenoma/Carcinoma

2

6 months

lymphomas, skin tumors

no

88

Mlh1+/- Apc1638/+

C57Bl/6

Small Intestine

Adenoma/Carcinoma

2

6 months

skin tumor

no

88

Mlh1-/- Apc1638/+

C57BL/6 x 129/Ola

Small Intestine

Adenoma/Carcinoma

45

3 months

 

no

88

Mlh1-/- ApcMin/+

C57BL/6

Small Intestine

Adenoma

139

2 months

 

no

89

Msh2-/-

C57BL/6 x 129/Ola

Small Intestine

Adenoma/Carcinoma

<1

6 months

lymphoma

no

71

TGFb models

 

 

 

 

 

 

 

 

Rag2-/- Tgfb1-/-

129S6 x CF1

Cecum/Colon

Mucinous Carcinoma

2

2-6 months

 

no

77

Rag2-/- Tgfb1+/-

129S6 x CF1

Cecum/Colon

Adenoma

2

2-6 months

 

no

77

Smad4+/-

C57BL/6

Stomach/

Duodenum

Hamartomatous Polyp

2

24 months

 

No

84

Smad4+/- ApcD716/+

C57BL/6

Small Intestine

Carcinoma

300

4 months

signet ring cell carcinoma

 

84

Smad3-/-

129/Sv

Colon

Mucinous Carcinoma

NR

6 months

rectal prolapse

yes

83

Smad3-/-

129 x C57BL/6

Cecum/Colon

Mucinous Carcinoma

NR

NR

rectal prolapse

NR

83

Immunodeficient

 

 

 

 

 

 

 

 

Il-10-/-

C57BL/6 x 129

Colon/Rectum

Colitis/Carcinoma

NR

2-6 months

 

no

97

Il-2 b2-microglobulin-/-

C57BL6 x 129

Rectum/Colon

Carcinoma

NR

6-12 months

 

no

98

Tcrα-/-

C57BL/6

Rectum/Colon

Colitis

NR

3-12 months

 

 

90

Gai2-/-

129Sv x C57BL/6J

Colon

Colitis/Carcinoma

1

3-9 months

altered thymocyte maturation

no

93

Carcinogen Treated

 

 

 

 

 

 

 

 

AOM

A/J

Colon

Adenoma/Carcinoma

36

6 months

 

NR

81

AOM

SWR/J

Colon

Adenoma/Carcinoma

16

6 months

 

NR

81

AOM

AKR/J

Colon

Adenoma/Carcinoma

<1

6 months

 

NR

81

MNU

NR

Small Intestine

Adenoma/Carcinoma

1.5

3-12 months

 

NR

76

MNG

C3H

Colon/ Small Intestine

Adenoma/Carcinoma

<1

11-20 months

Stomach SCC

NR

104

Other Models

 

 

 

 

 

 

 

 

Cdx2+/-

129/Sv x C57BL/6

Colon

gastric & intestinal heterotopia

10

3 months

 

no

109

Muc2-/-

C57BL/6 x 129/SvOla

Small & Large Intestine

Adenoma/Carcinoma

1

6-12 months

 

no

111

PI(3)Kinaseg-/-

C57BL/6

Rectum/Colon

Carcinoma

1+

3-6 months

 

peritoneal

82

N-Cadherin-/-

C57BL/6 x 129/Sv

Small Intestine

Colitis/Adenoma

NR

2-19 months

 

no

110

 

NR= not reported, AOM= Azoxymethane, MNU=N-methyl-N-nitrosourea, MNG= N-methyl-N-nitroso-N'nitroguanidine, SCC=squamous cell carcinoma

 

 

CONTACT US PRIVACY NOTICE DISCLAIMER ACCESSIBILITY APPLICATION SUPPORT  
National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov